THE FUNDAMENTALS, PATIENT SELECTION, & PE ALGORITHMS

Moderator(s)

• 

  Mona Ranade, MD

  Assistant Professor
  Stanford Health
  Interventional Radiology
  Los Angeles, California, United States

  Disclosure(s): AngioDynamics: Consultant
  Boston Scientific: Consultant
  Inari Medical: Consultant
  Medtronic: Consultant; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
• 

  Aditya Sharma, MBBS

  Director, Vascular Medicine and Co-Director Vascular Laboratory
  Sanger Heart and Vascular Institute, Advocate Health
  Vascular Medicine
  Charlotte, North Carolina, United States

  Disclosure(s): Akura Medical: Grants/Research Support Recipient
  Boston Scientific: Consultant
  enVVeno Medical: Consultant
  Novartis: Advisory Board

Panel(s)

• 

  Geoffrey Barnes, MD, MSc

  Associate Professor
  University of Michigan
  Vascular Medicine
  Ann Arbor, Michigan, United States

  Disclosure(s): Anthos: Consultant
  AstraZeneca: Consultant
  Bayer: Consultant
  Boston Scientific: Consultant; Grants/Research Support Recipient
  Bristol-Myers Squibb (BMS): Consultant
  Janssen: Consultant
  Pfizer: Consultant
  Sanofi: Consultant
• 

  Yulanka Castro, MD

  Interventional Cardiologist and Vascular Medicine Specialist
  University Hospitals
  Interventional Cardiology
  Cleveland, Ohio, United States

  Disclosure(s): Boston Scientific: Consultant
  Medtronic: Consultant
• 

  Robert Lookstein, MD, MHCDL

  Executive Vice Chairman, Dept of Diagnostic, Molecular, and Interventional Radiology
  Icahn School of Medicine at Mount Sinai
  Interventional Radiology
  New York, New York, United States

  Disclosure(s): Abbott Vascular: Consultant
  Boston Scientific: Advisory Board
  gore medical: Consultant
  Imperative Vascular: Advisory Board; Consultant
  Innova Vascular: Stockholder - Privately-held company
  Medtronic: Advisory Board
  Penumbra: Consultant
  Siemens: Consultant
  Summa: Stockholder - Privately-held company
  Thrombolex: Stockholder - Privately-held company
  Votis: Stockholder - Privately-held company
• 

  Gregory Piazza, MD

  Staff Physician
  Brigham and Women's Hospital
  Cardiology
  Boston, Massachusetts, United States

  Disclosure(s): BMS/Pfizer, Janssen, Alexion, Bayer, Amgen, BSC, Regeneron, 1R01HL164717-01: Grants/Research Support Recipient
  BSC, Amgen, BCRI, PERC, Syntactx, BMS, Janssen: Advisory Board

Presentations:

• 1:15pm - 1:22pm PT

  Cracking the PE Code: Choosing the Right Risk Stratification for Your Patient
  

  Speaker: Gregory Piazza, MD – Brigham and Women's Hospital
• 1:22pm - 1:29pm PT

  Beyond the Individual: How a Comprehensive PE Program Transforms Systems of Care
  

  Speaker: Geoffrey Barnes, MD, MSc – University of Michigan
• 1:29pm - 1:37pm PT

  Panel Discussion
• 1:37pm - 1:44pm PT

  AI Meets PE: The Future of Pulmonary Embolism
  

  Speaker: Robert Lookstein, MD, MHCDL – Icahn School of Medicine at Mount Sinai
• 1:44pm - 1:51pm PT

  Complex PE Case
  

  Speaker: Yulanka Castro, MD – University Hospitals
• 1:51pm - 2:00pm PT

  Panel Discussion